63 results on '"Janot, F"'
Search Results
2. Reconstruction of maxillectomy and midfacial defects using latissimus dorsi-scapular free flaps in a comprehensive cancer center
3. Chirurgia dei tumori sinusali
4. Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis
5. Cirugía de los tumores sinusales
6. Melanomi mucosi cervicofacciali
7. Melanomas mucosos cervicofaciales
8. Development of minimally invasive surgery for sinonasal malignancy
9. Développement de la chirurgie minimale invasive dans la prise en charge des cancers naso-sinusiens
10. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases
11. Les carcinomes adénoïdes kystiques ORL : une étude multicentrique prospective REFCOR de 95 cas
12. Laringectomia totale e faringolaringectomia totale
13. Laringectomía total y faringolaringectomía total
14. Résultats de la radiothérapie dans les carcinomes épidermoïdes du larynx avec atteinte sous-glottique
15. 909P Immunoscore-IC predicts nivolumab efficacy as adjuvant treatment after salvage surgery in head and neck cancer squamous cell carcinoma: The ADJORL1 trial
16. Volumes cibles en radiothérapie des adénopathies cervicales de primitif inconnu : état des lieux et pistes vers une approche sélective raisonnée sous l’égide du Refcor (Réseau d’expertise français des cancers ORL rares)
17. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
18. Paraneoplastic dermatomyositis accompanying nasopharyngeal carcinoma: Diagnosis, treatment and prognosis
19. Dermatomyosite paranéoplasique et carcinome nasopharyngé : diagnostic, traitement et pronostic
20. Place du curage ganglionnaire après chimioradiothérapie dans les carcinomes épidermoïdes des voies aérodigestives supérieures avec atteinte ganglionnaire initiale (nasopharynx exclu)
21. 855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)
22. Hyperselective intra-arterial preoperative chemotherapy in patients with squamous cell carcinoma of the oral cavity: preliminary results
23. Primary clear cell sarcoma of the tongue and surgical reconstruction: About a rare case report
24. The anterolateral thigh perforator flap in pharyngo-esophageal reconstruction
25. Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance
26. Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol
27. Airway fire during tracheostomy
28. Hypodermal metastasis of malignant melanoma to the cheek
29. Embrasement des voies aériennes au cours d’une trachéotomie
30. Métastase sous-cutanée jugale de mélanome malin
31. OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers
32. 109TiP - AcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types
33. EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy
34. OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer
35. OC-0272: Twice daily reirradiation with cetuximab vs once daily chemoRT after surgery in head and neck cancer
36. Clinical Relevance of Tumor Infiltrating Lymphocytes, PD-L1 Expression, and Correlation with HPV/P16 in Head and Neck Cancer Treated with Bio- or Chemoradiation Therapy
37. 1108TiP - Chemoradiotherapy versus radiotherapy in the treatment of salivary glands and nasal tumors: The GORTEC 2016-02 study
38. PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients
39. OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers
40. 823 - What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups
41. Erratum to “Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases” [Eur. Ann. Otorhinolaryngol. Head Neck Dis. 133 (1) (2016) 13–7]
42. 950O - Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
43. OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01)
44. Valeur histopronostique des engainements périnerveux dans les cancers supra glottiques
45. Infiltration de la glande thyroïde dans les laryngectomies totales
46. 997P - Results of Tpex (Docetaxel, Cisplatin, Cetuximab) Regimen Use in First Line Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M Scchn) in a Single Institution
47. Esthesioneuroblastomas: Bicentric Review of Clinical Features, Multimodal Treatment, and Long-term Outcome
48. Esthésioneuroblastome : étude rétrospective bicentrique de 43 patients, caractéristiques cliniques, modalités thérapeutiques et pronostic
49. 4111 Esthesioneuroblastoma in children and adolescents: experience on 11 cases with literature review
50. P052 Le poids est le paramètre nutritionnel le plus pertinent à surveiller bien au-delà de 6 mois, après chirurgie carcinologique des voies aéro-digestives supérieures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.